The Peruvian government Saturday announced the suspension of trials for the Chinese Sinopharm vaccine against COVID-19 after a "serious adverse event" was recorded in one of the trial participants, according to Reuters. 

In statements, the ministry of health said that the occurence is currently under investigation to detemine whether the serious reaction was related to the vaccine or otherwise, adding that the temporary suspension is merely a safety measure to ensure the health of the participants.

According to Reuters, the Chief Researcher at Cayetano Heredia University who is involved with the trial, said one volunteer had experienced weakening of his legs among other symptoms.

Sinopharm, which is conducting trials in Peru on around 12,000 volunteers, was set to complete the first phases of the trials in the coming few days.  In Peru, 36,544 people have died so far from the pandemic.

Also Read: Britain warns allergy-prone people against taking vaccine